Neuroprotective effects of ethanolic extract from dry Rhodiola rosea L. rhizomes
- 5 February 2021
- journal article
- research article
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 30 (2) , 287-297
Abstract
Rhodiola rosea L. rhizome has been used as a traditional medicine to treat fatigue, depression, and cognitive dysfunction. We aimed to authenticate R. rosea L. rhizome using the DNA barcoding technique and to quantify its main compounds, total phenolics, total flavonoids, and antioxidant capacity, and then to investigate their neuroprotective effects. The sequences of internal transcribed spacer and trnH-psbA of R. rosea L. rhizomes showed a 99% identity with those of NCBI GenBank database according to BLAST searches. Analysis using reversed-phase HPLC revealed five main compounds in R. rosea L. rhizome. Rhodiola rosea L. rhizome and two bioactive compounds, salidroside and tyrosol, showed free radical scavenging activity. Rhodiola rosea L. rhizome and its identified compounds protected neuronal PC-12 cells against oxidative stress and showed moderate acetylcholinesterase inhibition. Taken together, these results suggest that R. rosea L. rhizomes with bioactives can be used as a functional ingredient with potential for neuroprotection. Graphic abstractKeywords
This publication has 33 references indexed in Scilit:
- Behavioral symptoms related to cognitive impairmentNeuropsychiatric Disease and Treatment, 2013
- Protective Effect of DetoxifiedRhus vernicifluaStokes on Human Keratinocytes and Dermal Fibroblasts against Oxidative Stress and Identification of the Bioactive PhenolicsBioscience, Biotechnology, and Biochemistry, 2013
- Anti-Inflammatory and Neuroprotective Effects of Constituents Isolated fromRhodiola roseaEvidence-Based Complementary and Alternative Medicine, 2013
- Synthesis of Some Phenylpropanoid Glycosides (PPGs) and Their Acetylcholinesterase/Xanthine Oxidase Inhibitory ActivitiesMolecules, 2011
- RP-HPLC determination of phenylalkanoids and monoterpenoids inRhodiola roseaand identification by LC-ESI-TOFBiomedical Chromatography, 2009
- Acetylcholinesterase inhibitory-active components of Rhodiola rosea L.Food Chemistry, 2007
- Clinical trial ofRhodiola roseaL. extract SHR-5 in the treatment of mild to moderate depressionNordic Journal of Psychiatry, 2007
- Acetylcholine Esterase Inhibitors inRhodiola roseaPharmaceutical Biology, 2004
- Coumarins Isolated from Angelica gigas Inhibit Acetylcholinesterase: Structure−Activity RelationshipsJournal of Natural Products, 2001
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983